GPCA covers the latest fund, investment and industry news across our markets in two newsletters: NewsWatch is a weekly round-up of key transactions across asset classes; the Global Tech Brief is a bi-weekly review of tech transactions and innovations with cross-border applications. Subscribe in the left-hand sidebar.
Access past editions of NewsWatch here.
Kora, Fidelity, Tiger Global, Bow Wave, and Dragoneer Invest USD250m in Indian Food Delivery Startup Zomato
Kora Management, Fidelity Management and Research Company, Tiger Global Management, Bow Wave Capital Management, and Dragoneer Investment Group have invested USD115m, USD55m, USD50m, USD20m, and USD10m, respectively, in India-based food delivery startup Zomato at a reported USD5.4b valuation. Read More
BECO Capital Leads USD5m Series A for UAE’s Used Luxury Goods Marketplace North Ladder
BECO Capital led a USD5m Series A for UAE-based second-hand luxury products and electronics marketplace North Ladder (formerly BuyBack Bazaar). Read More
CPE Leads USD123.7m Series B+ for Chinese Agtech Wangjiahuan
CITIC Private Equity Funds Management led a CNY800m (approximately USD123.7m) Series B+ for China-based agtech Wangjiahuan, with participation from Paul Run Holding and Ziming Capital. Read More
GL Ventures and Temasek Lead USD230m Series C for Chinese Biotech Clover Biopharmaceuticals
GL Ventures and Temasek led a USD230m Series C for Clover Biopharmaceuticals, a China-based clinical-stage biotechnology company and vaccine developer, with participation from Oceanpine Capital and OrbiMed, and follow-on from Delos Capital. Read More
Gulf Capital Exits Turkish Internet Service Provider Turknet
Gulf Capital has exited its 70% stake in Turknet Iletisim Hizmetleri (Turknet) via a sale to a consortium of buyers including Celebiler Family and Re-Pie Portfoy Yonetimi. Gulf Capital originally invested in Turknet via its Gulf Capital Credit Opportunities Fund I in 2013. Read More
OrbiMed and WuXi Huiying Investment Lead USD40m Series C for Chinese Medical Technology Developer AnchorDx
OrbiMed and WuXi Huiying Investment led a USD40m Series C for AnchorDx, a China-based medical technology developer focused on DNA sequencing and diagnostics. Read More
Volition Capital Leads USD68m Investment in Ukrainian Low-Code CRM Company Creatio
Volition Capital led a USD68m investment in Creatio, a Ukraine-based software company providing a low-code platform for process management and CRM, with participation from Horizon Capital. Read More
IFC Invests USD10m in SP Ventures’ AgVentures II
IFC has invested USD10m in AgVentures II. The fund, which is managed by SP Ventures, targets investments in agtech companies in Latin America. This marks a third fund close for AgVentures II at BRL160m (approximately USD29.7m). Read More
KKR to Acquire Majority Stake in Telefonica Chile’s Fiber Optic Network in a Deal Valued at USD1b
KKR has agreed to acquire a majority stake in the existing fiber optic network of Telefonica Chile in order to establish an open access wholesale fiber optics company. As part of the agreement, Telefonica will hold a 40% stake in the new company. The transaction is valued at USD1b and is expected to close in the first half of 2021.… Read More
Earlybird VC Reaches USD241m Final Close for Emerging Europe VC Fund
Earlybird Venture Capital has reached a EUR200m (approximately USD241m) final close for its Digital East Fund II, a vehicle targeting early-stage investments in Emerging Europe. Read More
Winter Capital Partners and Russia-China Technology Investment Fund Invest USD10m in Russia’s Algorithmics
Winter Capital Partners and the Russia-China Technology Investment Fund have invested USD10m in Algorithmics, an international school of mathematics and programming based in Russia, as part of the company’s Series A. Winter Capital Partners also acquired Algorithmics stakes from a number of minority shareholders. Read More
Lilly Asia Leads USD90m Series B for Chinese Biotech Regor Therapeutics
Lilly Asia Ventures led a USD90m Series B for Regor Therapeutics, a China-based clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders, and metabolic diseases. Loyal Valley Capital, Lanting Capital, TF Capital, and Vertex Ventures China also participated in the round. Read More